Biofourmis Everion+ (G2)
System, Network And Communication, Physiological Monitors. 510(k) K233418, from Biofourmis Singapore Pte., Ltd. (Singapore, SG). Product code MSX, class 2.
As of Nov 19, 2026, K233418 is an FDA 510(k) held by Biofourmis Singapore Pte., Ltd., substantially equivalent on May 9, 2024 after 212 days, with no recalls tied to it in FDA's recall database.
- Review time: 212 days
- Recalls: 0
Biofourmis Everion+ (G2) provides continuous monitoring of the following vital signs in adults, 18 years of age or older, when at rest: • Pulse rate • Respiration rate • Movement • Skin temperature Biofourmis Everion+ (G2) also provides Blood oxygen saturation (SpO2) as a vital for continuous data collection in adults, 18 years of age or older, when at rest.
- Everion+ SystemK213863 · Biofourmis Singapore Pte., Ltd. · Feb 23, 2023
- Current Health Monitoring System Gen 2 (G2)K210133 · Current Health · Sep 3, 2021
- eClinicsK260075 · Ceiba Healthcare US, Inc. · Oct 7, 2026
- Digistat CareK261287 · Ascom Ums Srl Unipersonale · Sep 12, 2026
- Dashboard (P007000)K260211 · Hill-Rom, Inc. · Aug 13, 2026
- Corsano CardioWatch 287-2 SystemK261367 · Corsano Health B.V. · Jul 26, 2026
- IntelliVue Measurement Rack 6000 (867317)K253654 · Philips Medizin Systeme Böblingen GmbH · Mar 30, 2026
- TigerConnect Alarm ManagementK243270 · Tigerconnect · Sep 30, 2025
- BeneVision Central Monitoring SystemK242728 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 31, 2025
- Central StationK242750 · Nihon Kohden Digital Health Solutions, LLC · Jun 5, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 10, 2023
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files